Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
Study NCT ID:
NCT04240106
Status:
COMPLETED
Last Update Posted:
2024-02-16
First Post:
2020-01-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Sponsor:
MedSIR
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-14
First Submit QC Date:
None
Study First Post Date:
2020-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-15
Last Update Post Date:
2024-02-16
Last Update Post Date Type:
ACTUAL